Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction | Zendy

Julian P. T. Higgins | Zendy; David J. Spiegelhalter | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction

Author(s) -

Julian P. T. Higgins,

David J. Spiegelhalter

Publication year - 2002

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/31.1.96

Subject(s) - myocardial infarction , skepticism , perspective (graphical) , meta analysis , medicine , bayesian probability , clinical trial , intensive care medicine , cardiology , psychology , epistemology , philosophy , computer science , artificial intelligence

There has been extensive discussion of the apparent conflict between meta-analyses and a mega-trial investigating the benefits of intravenous magnesium following myocardial infarction, in which the early trial results have been said to be 'too good to be true'.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research